Status: Not yet recruiting
Cell-based Non-invasive Prenatal Test Workflow
The aim of this study is to optimize a new non-invasive prenatal screening method based on the capture of fetal cells from maternal blood and to complete its development by obtaining maternal blood samples during the first trimester of pregnancy.
Participants needed: 1,400
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: Menarini Silicon BiosystemsUpdated: May 5, 2026
Eligibility criteria
Informed consent signed before any study-specific procedures [+2]
Unable to provide informed consent [+2]